A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Phase 2TerminatedNCT00090532

Pfizer155 enrolled

Overview

AG-013,958 is being studied to treat patients with Age-Related Macular Degeneration. A total of 144 subjects may be enrolled in the trial. Subjects will be male or female at least 55 years of age with "wet" age-related macular degeneration.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

155

Conditions

Age-Related Macular Degeneration

Interventions

AG-013,958DRUG

Eligibility

Sex: ALLMin age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and/or female subjects \>=55 years of age * Subfoveal choroidal neovascularization complicating age-related macular degeneration * Subjects who are informed of, and willing and able to comply with, the investigational nature of the study and are able to provide written informed consent in accordance with institutional and regulatory guidelines Exclusion Criteria: * Other serious ocular diseases or conditions, including diabetic retinopathy and glaucoma, that are likely to compromise visual acuity within 1 year

Locations (39)

Outcomes

Primary Outcomes

To evaluate the ocular and systemic safety of the study drug

Secondary Outcomes

To evaluate the visual acuity change after study treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Pfizer Investigational Site

Mesa, Arizona, United States

Pfizer Investigational Site

Oro Valley, Arizona, United States

Pfizer Investigational Site

Phoenix, Arizona, United States

Pfizer Investigational Site

Sun City, Arizona, United States

Pfizer Investigational Site

Tucson, Arizona, United States

Pfizer Investigational Site

Tuscon, Arizona, United States

Pfizer Investigational Site

Beverly Hills, California, United States

Pfizer Investigational Site

Fort Myers, Florida, United States

Pfizer Investigational Site

Tampa, Florida, United States

Pfizer Investigational Site

Iowa City, Iowa, United States

...and 29 more locations